Teva Launches ProAir Dry Powder Digital Inhaler

Teva’s First Generic Of Merck Sharpe & Dohme Is For Asthma & COPD Patients

 
• By Akriti Seth

After getting FDA approval in 2018, Teva finally launches its ProAir Digihaler. The company will be making its complete ‘Digihaler’ portfolio available in the US by prescription later this year.

Inhaler
After Cipla & Perrigo, Teva announces launch of albuterol sulfate inhalation powder • Source: Shutterstock

More from Generics

More from Products